1Bellosta S,Ferri N,Bemini F,et al.Non-lipid related effects of statins.Ann Med,2000,32:164-176.
2Mundy G,Garrett R,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins.Science,1999,286:1946-1949.
3Sugiyama M,Kodama T,Konishi K.et al.Compactin and simvastatin,but not pravastatin,induce bone morphogenetic protein-2 in human osteosarcoma cells.Biochem Biophys Res Co mmun,2000,271:688-692.
4Maeda T,Matsunuma A,Kawane T,et al.Simvastatin promotes osteoblast differentiation and mineralizatong in MC3T3-E1 cells.Biochem Biophys Res Commun,2001,280:874-877.
5Maeda T,Matsunuma A,Kurahashi I,et al.Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.J Cell Biochem,2004,92:458-471.
6Ohnaka K,Shimoda S,Nawata H,et al.Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.Biochem Biophys Res Commun,2001,287:337-342.
7Li X,Cui Q,Kao C,et al.Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures.Bone,2003,33:652-659.
1Harris SE, Bone wald LF, Harris MS, et al. Effcets of TGF on bone nodule formation and expression of bone morphogenetic protein-2, osteocalcin, osteopontin, alkaline phosphatase and type I collagen mRNA in prolonged cultures of fetal rat calvarial osteobl
2Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science, 1999,286:1946-1949.
3Mundy GR, Boyce B, Hughes D, et al. The effects of cytokines and growth factors on osteoblastic cells. Bone, 1995,17:17-75S.
1Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins [ J ]. Science, 1999 ;286 (5446) : 1946-9.
2Rejnmark L, Olsen ML, Johnsen SP,et al. Hip fracture risk in statin users-a population-based Danish case-control study [ J ].Osteoporos Int,2004;15(6) :452-8.
3Hatzigeorgiou C, Jackson JL Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis [ J ]. Osteoporos Int, 2005 ; ( 8 ) :990-8.
4Majima T, Komatsu Y, Fukao A, et al. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia [ J]. Endocr J,2007 ;54( 1 ) : 145-51.
5Bjamason NH, Riis B J, Christiansen C. The effect of fluvastatin on parameters of bone remodeling[ J ]. Osteoporos Int ,2001 ; 12 ( 5 ) :380-4.
6Kajinami K, Takekoshi N, Matsui S,et al. Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia[ J ]. Am J Cardiol,2003; 92(9) :1113-6.
7Rosenson RS, Tangney CC, Langman CB, et al. Short-term reduction in bone markers with high-dose simvastatin [ J ]. Osteoporos Int, 2005 ; 16 (10) : 1272-6.
8Rejnmark L, Olsen ML, Johnsen SP, et al. Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int, 2004,15(6) :452-458.
9Hatzigeorgiou C, Jackson JL. Hydroxymethylglutaryl-coenzyme a reductase inhibitors and osteoporosis: a meta-analysis. Osteoporos Int, 2005, (8) :990-998.
10Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science, 1999,286(5446):1946- 1949.
